Sort
261,768 grants matching “gene therapy”
Hypertension Pharmacogenetics
$855,574University Of Florida · R01 · FY2004 · HL
Rectifying splicing mutations in blood disorders by gene editing
$855,537Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2023 · HL
The Gut Microbiota and Graft versus Host Disease (GVHD)
$855,510David Neal Fredricks · Fred Hutchinson Cancer Research Center · R01 · FY2021 · AI
IGF::OT::IGF - GTRP Coordinating Center services. CAN 8470187; FY13; $803,731
$855,485Susan Sepelak · Social And Scientific Systems, Inc. · N01 · FY2016 · HL
Mild Hypothermia Catheter for Reperfusion Injury
$855,323Aditya Pandit · 3dt Holdings, Llc · R44 · FY2017 · HL
New approaches to targeting cell cycle proteins for cancer treatment
$855,249Piotr Sicinski · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children
$855,240Max A Seibold · National Jewish Health · R01 · FY2018 · HL
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens
$855,174Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Transcription Regulation In Vertebrate Eye Development
$855,132Heinz Arnheiter · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Micropublications for Automating Genome Sequence Variant Interpretation from Medical Literature
$855,024Mark Julin Kiel · Genomenon, Inc. · R44 · FY2021 · HG
Micropublications for Automating Genome Sequence Variant Interpretation from Medical Literature
$855,024Mark Julin Kiel · Genomenon, Inc. · R44 · FY2022 · HG
Cellular Interactions with Thrombospondin
$855,020David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Opioid Impacts on T Cell Pathways and Epigenetics to Modulate HIV Integration, Latency and Reservoirs.
$855,007David Mitchell Smith · University Of California, San Diego · R33 · FY2022 · DA
NIH Director's Pioneer Award
$855,000Rosalind A Segal · Dana-Farber Cancer Inst · DP1 · FY2007 · OD
NIH Director's Pioneer Award
$855,000Rosalind A Segal · Dana-Farber Cancer Inst · DP1 · FY2008 · OD
NIH Director's Pioneer Award
$855,000Rosalind A Segal · Dana-Farber Cancer Inst · DP1 · FY2010 · OD
NIH Director's Pioneer Award
$855,000Rosalind A Segal · Dana-Farber Cancer Inst · DP1 · FY2009 · OD
Chronic Kidney Disease Prognosis Consortium (CKD-PC)
$854,984Josef Coresh · New York University School Of Medicine · R01 · FY2025 · DK
Gene Expression Signatures to Predict Treatment Response in Systemic Sclerosis
$854,879Michael W Fanger · Celdara Medical, Llc · R44 · FY2015 · AR
DNA METHYLATION, GENE REGULATION, AND CANCER
$854,867Whitehead Institute For Biomedical Res · R01 · FY2005 · CA
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
$854,865Michael Rutledge Debaun · Vanderbilt University Medical Center · U01 · FY2022 · HL
Protection against early SIV brain injury with adjunctive therapy to cART
$854,805Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2022 · NS
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
$854,803Allan D. Kirk · Duke University · U19 · FY2021 · AI
Epstein-Barr Virus Associated Disorders
$854,802Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral Therapy
$854,741John Koethe · Vanderbilt University Medical Center · R01 · FY2022 · DK